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Abstract
 
Immature myeloid dendritic cells (DCs) express only low levels of major histocompatibility
complex (MHC) class II but express high levels of CD1 a, b, and c antigen-presenting mole-
cules at the cell surface. As V
 
 
 
1
 
 
 
 
 
 
 
/
 
 
 
 T cells are the main tissue subset of 
 
 
 
/
 
 
 
 T cells and they
are known to recognize CD1c in the absence of specific foreign antigen recognition, we exam-
ined the possible interaction of these T cells with immature DCs. We show that CD1-
restricted 
 
 
 
/
 
 
 
 T cells can mediate the maturation of DCs. DC maturation required cell–cell
contact and could be blocked by antibodies against CD1c. The maturation process was partially
mediated by tumor necrosis factor 
 
 
 
. Importantly, immature DCs matured in the presence of
lipopolysaccharide and CD1-restricted 
 
 
 
/
 
 
 
 T cells produced bioactive interleukin-12p70. In ad-
dition, these DCs were able to efficiently present peptide antigens to naive CD4
 
 
 
 T cells.
CD1-restricted 
 
 
 
/
 
 
 
 T cell recognition of immature DCs provides the human immune system
with the capacity to rapidly generate a pool of mature DCs early during microbial invasion.
This may be an important source of critical host signals for T helper type 1 polarization of anti-
gen-specific naive T cells and the subsequent adaptive immune response.
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Introduction
 
Dendritic cells (DCs)
 
*
 
 represent a pool of professional
APCs that plays an essential role in the initiation of host T
cell immunity (1). The maturational state of these cells is
critical in determining their function. DCs residing in pe-
ripheral tissues exist in an immature state where they are
uniquely adapted for antigen internalization and processing
(2). After interaction with microbial antigens or host cellu-
lar signals, maturation and migration to regional lymph
nodes occurs. Mature DCs in lymphoid sites down-regu-
late their rate of antigen uptake and express increased cell
surface levels of MHC class II and costimulatory molecules
such as B7.2 (CD86) that enable them to present antigens
to naive CD4
 
 
 
 and CD8
 
 
 
 T cells promoting the adaptive
immune response (3).
During host infection, microbial antigens such as LPS
provide critical innate signals for DC maturation via cell
surface Toll-like receptors (TLRs). However, maturation
of DCs by microbial stimuli alone may promote a short-
lived burst of IL-12 leading to an “exhausted” DC popula-
tion unable to produce this cytokine upon subsequent
encounter with naive T cells in the lymph node (4). The
ability of the host to successfully defend against microbial
invasion is, therefore, dependent upon both innate signals
provided by microbial products as well as T cell signals.
Studies in mice have demonstrated the important role of
host T cells in both the development of normal DCs as
well as the ability of these DCs to efficiently prime naive T
cells to respond to microbial invasion. For example,
Rag2
 
 
 
/
 
 
 
 mice do not develop normal numbers of DCs and
the ability to efficiently present antigens to naive T cells by
DCs is impaired (5). In addition, members of the TNF
family of cell surface receptors, expressed by host T cells,
including CD40L (6), RANKL (7), and FasL (8) have been
demonstrated to be important mediators of human DC
maturation in vitro and in mice, in vivo. Finally, it has be-
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come increasingly clear that optimal production of inflam-
matory cytokines such as heterodimeric IL-12 by the DCs,
promoting efficient Th1 polarization of naive T cells, is
also influenced by signals imparted by host T cells. Yet, the
specific T cell populations capable of providing this variety
of T cell signals for DC maturation remain poorly defined.
As immature DCs express high levels of CD1a, b, and c
molecules (9), we considered the possibility that T cells
recognizing CD1 might be capable of interacting with im-
mature DCs. Here, we provide evidence that a subpop-
ulation of V
 
 
 
1
 
 
 
 
 
 
 
/
 
  
 
T cells can selectively stimulate
monocyte-derived dendritic cells to undergo maturation.
Importantly, these 
 
 
 
/
 
 
 
 T cells recognize CD1 on the sur-
face of immature DCs in the absence of a specific foreign
antigen. Upon recognition of CD1c, they secrete TNF-
 
 
 
and other factors that, together with microbial products
such as LPS, induce immature DCs to mature and to pro-
duce heterodimeric IL-12p70.
 
Materials and Methods
 
mAbs and Blocking Reagents.
 
The following mAbs were used
for flow cytometry and blocking experiments: P3 (IgG control),
F10/21A3 (anti-CD1c; reference 10), 10D12 (anti-CD1a; refer-
ence 11), OKT6 (anti-CD1a; reference 12), IgG1-FITC, IgG1-
PE, IgG2a-PE, CD83-PE, CD86-PE (anti-B7.2), anti-CD40
ligand-PE, anti-TNF-
 
 
 
, anti-IFN-
 
 
 
, anti-Fas ligand (all
from BD Biosciences), osteoprotegerin (OPG; PeproTech), and
 
 
 
TCS1(anti-V
 
 
 
1-J
 
 
 
1; Pierce Chemical Co./Endogen).
 
T Cell Lines and Clones.
 
CD1c-reactive V
 
 
 
1
 
 
 
 
 
 
 
/
 
 
 
 clones
JR.2 and XV.1 were derived by limited dilution cloning from
normal donor peripheral blood as described previously (13).
V
 
 
 
1
 
 
 
 
 
 
 
/
 
 
 
 clones 10G4 and 20H8 were isolated from peripheral
blood lymphocytes from normal donors by Ficoll-Hypaque cen-
trifugation. Cells were stained with saturating concentrations of
anti-V
 
 
 
1 mAb 
 
 
 
TCS1-FITC and positive cells were directly
sorted using a Beckman Coulter EPICS Elite fluorescence-acti-
vated cell sorter (Beckman Coulter) at one cell per well into 96-
well round-bottomed tissue culture plates in a volume of 200 
 
 
 
l
containing 5 
 
  
 
10
 
4
 
 irradiated (5,000 rads) heterologous PBMCs
and 5 
 
 
 
 10
 
4
 
 irradiated (7,500 rads) EBV-transformed B lympho-
blastoid cells as feeders in RPMI medium supplemented with
10% fetal bovine serum (Hyclone), PHA-P (1:4,000 final dilu-
tion; Difco), and 2 nM IL-2 (Chiron Corp.). The bisphosphonate
reactive V
 
 
 
2V
 
 
 
2 line was generated by culture of normal donor
PBMCs in 10 
 
 
 
M Risedronate and 2 nM IL-2 for 28 d.
 
Monocyte-derived DC Maturation Assays.
 
Monocyte-derived
DCs were generated from human blood monocytes that were
isolated from the by-products of platelet pheresis and induced to
differentiate and express CD1a, CD1b, and CD1c by incubation
with GM-CSF and IL-4 as described (14). Immature DC were
then cultured in 24-well tissue culture plates at a concentration of
1 
 
  
 
10
 
6
 
 cells/ml for 1–3 d in RPMI complete medium alone or
in the presence of 10 ng/ml 
 
Escherichia coli
 
 LPS (Sigma-Aldrich),
50 ng/ml TNF-
 
 
 
, or 
 
 
 
/
 
 
 
 T cell clones (T:DC ratio ranging from
1:3 to 1:27) as maturation stimuli. mAbs used in blocking studies
were added at a final concentration of 20 
 
 
 
g/ml. After coculture
of DCs with T cells or the maturation stimuli above, cells were
washed and stained with PE-conjugated mAbs against CD83 and
CD86 and analyzed by flow cytometry (FACSort™; Becton
Dickinson). CD83 results are expressed as percentage of positive
 
cells compared with negative cells stained with an isotype-
matched control antibody. CD86 results are expressed as mean
fluorescence intensity (MFI).
 
FITC–Dextran Endocytosis.
 
Measurement of soluble antigen
uptake by immature DCs was performed by culturing immature
DCs in the presence of medium, TNF-
 
 
 
 (50 ng/ml) of the 
 
 
 
/
 
 
 
 T
cell clone JR.2 (T:DC ratio 
 
 
 
 
 
1:10) for 48 h to induce matura-
tion. DCs were then washed and resuspended at 10
 
6
 
 cells/ml.
FITC–Dextran (MW 
 
  
 
40,000; Sigma-Aldrich) was added at a
concentration of 1 mg/ml and cells were incubated from 0–60
min at 37
 
 
 
C to allow endocytosis to occur. This concentration is
saturating for uptake via the mannose receptor so that differences
in uptake primarily reflect changes in macropinocytosis (15). After
the incubation period, DCs were washed in medium and FITC–
Dextran MFI was determined by flow cytometry as described.
 
Confocal Microscopy.
 
After maturation for 48 h in the presence
of medium alone, 50 ng/ml TNF-
 
 
 
 or 
 
 
 
/
 
 
 
 T cell clone JR.2,
DCs were adhered on glass slides by cytospin, fixed, and perme-
abilized as described previously (16). The cells were then double-
labeled with FITC-conjugated LB3.1 mAb to HLA-DR and
rabbit polyclonal antiserum against LAMP-1 (17), followed by
incubation with Texas Red–conjugated donkey F(ab
 
 
 
)2 antibody
to rabbit IgG (Jackson ImmunoResearch Laboratories). Labeled
cells were then examined using a Leica TCS-NT confocal laser
scanning microscope fitted with krypton and argon lasers.
 
Measurement of Soluble Cytokines by ELISA.
 
Immature mono-
cyte-derived DCs were harvested following 48 h of culture in
IL-4 and GM-CSF. Cell surface expression of CD1a, CD1b, and
CD1c was confirmed by mAb staining and flow cytometry and
the DCs were plated in 96-well round bottom plates at a concen-
tration of 10
 
6
 
/ml in RPMI complete medium. 
 
 
 
/
 
 
 
 clone JR.2, at
a T cell:DC ratio of 1:9, and/or LPS (10 ng/ml) with and with-
out blocking mAbs against CD1a, CD1c, IFN-
 
 
 
, or isotype-
matched control antibody. After coculture for 24 h, supernatants
were harvested and analyzed for TNF-
 
 
 
, IFN-
 
 
 
, IL-12p70, IL-4,
and IL-13 by sandwich ELISA assay using antibody pairs pur-
chased from Pierce Chemical Co./Endogen. Results were ex-
pressed as ng/ml 
 
 
 
 SD.
 
Presentation of KLH to CD45RO
 
 
 
CD4
 
 
 
 Naive T Cells by
DCs.
 
Immature monocyte-derived DCs were isolated as de-
scribed by culture in GM-CSF and IL-4 for 3 d. DCs were cul-
tured in 24-well tissue culture plates at 10
 
6
 
 cells/ml for 72 h in
the presence of TNF-
 
 
 
 (50 ng/ml), 
 
 
 
/
 
 
 
 clone JR.2 (T cell:DC
ratio 
 
  
 
1:10), or medium alone with and without 25 
 
 
 
g/ml
Keyhole Limpet Hemacyanin (Calbiochem). DC expression of
CD83 and CD86 was then measured by mAb staining and flow
cytometry to assess phenotypic maturation. These DCs were
washed, irradiated (5,000 rads), and then cultured with 5 
 
  
 
10
 
4
 
autologous CD4
 
 
 
CD45RA
 
 
 
 naive T cells (isolated using a nega-
tive selection column (R&D Systems) per well at a DC:T cell ra-
tio of 1:10 for 5 d. The T cells derived were 
 
 
 
98% positive for
CD4 and CD45RA. During the final 12 h of culture, cells were
pulsed with 1 
 
 
 
Ci [
 
3
 
H]thymidine (2 Ci/mmol; New England
Nuclear) and then harvested using a Tomtec harvester. Filter
mats were counted on a Betaplate scintillation counter (Wallac).
Results were expressed as relative stimulation index.
 
Allogeneic Mixed Lymphocyte Reaction.
 
Immature monocyte-
derived DCs were isolated as described previously. DCs were
cultured in 24-well tissue culture plates at 10
 
6 cells/ml for 72 h
in the presence of TNF-  (50 ng/ml),  /  clone JR.2 (T cell:DC
ratio   1:3), or medium alone and DC expression of CD83 and
CD86 was then measured to assess phenotypic maturation.
These DCs were washed, irradiated (5,000 rads), and then cul-1577 Leslie et al.
tured with 105 allogeneic CD4  T cells (isolated by immuno-
magnetic selection (Miltenyi Biotec) per well for 7 d. During the
final 12 h of culture, cells were pulsed with 1  Ci [3H]thymi-
dine (2 Ci/mmol; New England Nuclear) and counted as de-
scribed previously.
Results
 /  T Cells Promote Maturation of Immature DCs. Out-
side the thymus, only myeloid dendritic cells are known to
express all of the group I (CD1a, CD1b, and CD1c) and
group2 (CD1d) CD1 isoforms (9). As we had previously
isolated human  /  T cells expressing V 1 TCRs that rec-
ognize CD1c in the absence of exogenous microbial anti-
gens (13), we hypothesized that this T cell population
might mediate the maturation of immature monocyte-
derived dendritic cells. Fresh blood monocytes were cultured
with GM-CSF and IL-4 for 2 to 3 d, in vitro, to obtain a
pool of immature monocyte-derived DCs. Cocultures of
such DCs with CD1-reactive  /  T cells clones resulted
in increased cell surface expression of the costimulatory
molecule CD86 (B7.2) and an increased percentage of
cells expressing the maturation marker CD83, consistent
with DC maturation. For example, culture of the CD1c-
restricted  /  T clones JR.2 and XV.1 with immature
DCs at ratios ranging from 1:3 to 1:27 T cells per DC for
48 h led to a 9- and 13-fold increase in DC cell surface ex-
pression of CD86 for JR.2 and XV.1, respectively (from
MFI   196.7 to MFI   2,565.1 for JR.2 and MFI  
1,742.6 for XV.1), as well as an increase in the percentage
of CD83  DCs (from 3.5 to 75.5% for JR.2 and 61.7% for
XV.1) when compared with DCs cultured in medium
alone. (Fig. 1 A).
We next compared the CD1c-reactive  /  clone JR.2
to other  /  T cells that are not restricted by CD1 in terms
of their ability to mediate maturation of immature DCs.
Again, coculture of JR.2 with immature DCs led to in-
creased cell surface expression of CD86 (from MFI  
177.9 to MFI   2,517.4) and an increase in the percentage
of CD83  DCs (from 20.49 to 92.32%). This level of mat-
uration was greater than that seen when DCs were cultured
in the presence of 50 ng/ml TNF-  as a maturation stimu-
lus both in terms of CD86 expression (MFI   2,517 for
JR.2 vs. 901 for TNF- ) and the percentage of CD83 
cells (92% for JR.2 vs. 78.31% for TNF- ). In contrast, co-
culture of immature DCs with T cell clones 10G4 and
20H8, which express V 1 TCRs but are not CD1-
restricted, as well as a V 2V 2  /  line reactive against a
bisphosphonate antigen (V 2), had no effect upon CD86
cell surface expression or the percentage of DCs expressing
CD83 further supporting a role for CD1c in the matura-
tion process (Fig. 1 B).
 /  T Cell Maturation of Immature DCs Is Mediated by
CD1c. As only certain  /  T cells were able to induce
the maturation of DCs, we wished to determine if recogni-
tion of CD1c by these T cells was critical for inducing DC
maturation. During a 48-h coculture of  /  clone JR.2
with immature DCs at a T cell:DC ratio of 1:9, treatment
with anti-CD1c mAb F10/21A3 inhibited up-regulation of
CD83 and CD86 by 64 and 78%, respectively, when com-
pared with DCs cultured in medium alone. Treatment
with a mAb directed against CD1a (OKT6) had no such
effect (Fig. 2). These data indicate that CD1c recognition
by certain  /  T cells is required for the ability to induce in
vitro monocyte-derived DC maturation.
DCs Cultured with CD1c-restricted  /  T Cells Display the
Morphologic and Functional Characteristics of Mature DCs.
To further evaluate the characteristics of DC maturation
that occurred, we assessed morphologic and functional
markers of DC maturation. In immature DCs, antigen up-
take via macropinocytosis and expression of pattern recog-
nition receptors (PRRs) for microbial products equip these
cells to internalize a wide array of soluble antigens in pe-
ripheral tissues (18).
We first investigated the ability of DCs matured in the
presence of CD1c-reactive  /  T cells to internalize solu-
Figure 1. CD1-restricted  /  T cells induce phenotypic
DC maturation. (A) Immature monocyte-derived DCs
cultured with V 1  CD1-restricted T cell clones JR.2 and
XV.1 for 48 h expressed increased CD83 and CD86 cell
surface molecules when compared with DCs cultured in
medium alone as assessed by mAb staining and flow cy-
tometry. (B) Immature DCs cultured with CD1c-
restricted  /  clone JR.2 or TNF-  (50 ng/ml) for 48 h
expressed increased levels of CD83 and CD86 cell surface
molecules. Culture of DCs with V 1  clones 10G4, 20H8,
and a V 2   /  line (which are not CD1-restricted) all
failed to promote maturation of DCs as assessed by CD83
and CD86 cell surface expression. Open squares, medium
alone; open triangles, TNF- , filled squares, JR.2; dia-
monds, XV.1; triangles, 10G4; inverted triangles, 20H8;
circles, V 2 line. These results are representative of four
independent experiments using different DC donors.1578 CD1-mediated  /  T Cell Maturation of Dendritic Cells
ble antigens. After a 48-h culture with  /  clone JR.2 (T
cell:DC ratio    1:9), TNF-  (50 ng/ml), or medium
alone, DCs were assessed for their ability to internalize
the soluble fluorescent antigen FITC–Dextran (MW  
40,000; 1 mg/ml concentration) during a 60-min time
course. DCs cultured in the presence of JR.2 (MFI   132)
or TNF-  (MFI    100) showed decreased uptake of
FITC–Dextran at 60 min when compared with immature
DC cultured in medium alone (MFI   369), consistent
with their functional maturation (Fig. 3 A).
In immature DCs, a majority of MHC class II molecules
are stored in an acidic lysosomal compartment, where pep-
tide loading is proposed to occur. As DCs mature, a dra-
matic shift in the cellular location of MHC class II occurs
as peptide antigen-loaded MHC class II molecules are effi-
ciently transported to the plasma membrane. Concur-
rently, internalization of MHC class II–peptide complexes
is down-regulated, promoting an increased ability of the
mature DCs to present peptide antigens to MHC class II–
restricted T cells (2). As a shift in the cellular location of
the predominant pool of MHC class II molecules from in-
tracellular lysosomes to the plasma membrane occurs as
DCs mature, we next performed two-color confocal laser
microscopy to assess for these morphologic changes during
Figure 2.  /  T cell–induced DC maturation is mediated by CD1c.
Immature monocyte-derived DCs were cultured with the CD1c-
restricted  /  clone JR.2 at a T cell:DC ratio of 1:9 for 48 h in culture
medium or in the presence of anti-CD1 mAb blocking. Treatment with
anti-CD1c mAb F10/21A3 inhibited up-regulation of CD83 and CD86
by 64 and 78%, respectively. Blocking with mAb directed against CD1a
(OKT6) did not inhibit maturation. These results are representative of
three independent experiments using different DC donors.
Figure 3. CD1c-reactive T cells induce functional DC maturation. (A) De-
creased uptake of soluble FITC dextran by mature DCs. Immature DCs were
cultured in the presence of TNF-  (50 ng/ml),  /  clone JR.2 (T cell:DC ra-
tio   1:9), or medium alone for 48 h. These DCs were then washed and cul-
tured in the presence of FITC–dextran during a 60 min time course and anti-
gen uptake was assessed by flow cytometry. Note that DCs matured in the
presence of clone JR.2 or TNF  had decreased uptake of FITC–dextran con-
sistent with functional maturation. Open squares, medium; filled squares, JR.2;
triangles, TNF- . (B) Redistribution of MHC class II molecules in maturing
DCs. Confocal microscopy was
performed on DCs matured in the
presence of TNF- , JR.2 (T cell:
DC ratio   1:9) or medium alone.
Cells were labeled with mAb
against MHC class II (green stain-
ing) and the lysosomal marker
LAMP 1 (red staining). Colocaliza-
tion of these molecules is repre-
sented by the merged image (yel-
low). Note that DCs matured in the
presence of JR.2 or TNF-  have
increased staining of cell surface
MHC class II and minimal colocal-
ization with LAMP 1. Bar   2  m.
(C) DC expression of cell surface
CD83. DCs cultured in the pres-
ence of TNF-  or JR.2 expressed
increased levels of the maturation
marker CD83 as assessed by mAb
staining and flow cytometry. These
results are representative of three
independent experiments using dif-
ferent DC donors.1579 Leslie et al.
culture of immature DCs with CD1c-restricted  /  T
cells. After 48 h culture of immature DCs in the presence
of  /  clone JR.2 (T cell:DC ratio   1:9), TNF-  (50
ng/ml), or medium alone, DCs were permeabilized with
Saponin and stained with mAbs against MHC class II
(HLA-DR-FITC; green staining) and the late endo-
some/lysosomal marker LAMP-1 (LAMP-1-Texas Red;
red staining). Immature DCs cultured in medium alone
showed a high degree of colocalization of MHC class II
and LAMP-1 (yellow staining) in intracellular vesicles
with low intensity MHC class II cell surface staining
(green). In contrast, DCs cultured in the presence of ei-
ther TNF-  or the  /  clone JR.2 demonstrated mini-
mal colocalization of MHC class II and LAMP-1 mole-
cules but intense staining of MHC class II on the cell
surface (Fig. 3 B). These results are consistent with a shift
in MHC class II molecules from lysosomes to the plasma
membrane, as well as decreased recycling of MHC class
II molecules indicating increased DC maturation. Mature
DCs up-regulate the expression of costimulatory mole-
cules such as CD80, CD86, and CD40, increasing their
ability to stimulate these antigen-specific T cells.
To confirm that phenotypic maturation paralleled the
changes in antigen uptake and MHC class II redistribu-
tion, we assessed the percentage of CD83  DC during
the same assay. Confirming our previous observations,
the percentage of cells expressing CD83 increased in the
presence of TNF-  (76%) or the CD1c-restricted  / 
clone JR.2 (79%) but not in culture with medium alone
(16%; Fig. 3 C).
Phenotypic Maturation of DCs by CD1-restricted  /  T
Cells Is Partially Mediated by the Cytokine TNF- . The
Th1 cytokines IFN-  (19) and TNF-  (20) have been ex-
tensively characterized as soluble factors that are important in
DC maturation. For example, production of IFN-  by host
lymphocytes including CD8  T cells (21) and NK cells (22)
was found to promote the ability of maturing DCs to pro-
duce IL-12p70 leading to Th1 polarization of antigen spe-
cific naive T cells. Therefore, we assessed the ability of  / 
clone JR.2 to produce these cytokines during coculture with
CD1 expressing immature DCs. Both IFN-  (1.4   0.05
ng/ml) and TNF-  (14.3   3.3 ng/ml) were produced by
CD1-specific  /  T cells as assessed by ELISA, and cytokine
production was inhibited by 89% using mAb against CD1c
but not by mAb against CD1a (Fig. 4 A). Production of the
Th2 cytokines IL-4 and IL-13 was below the limit of detec-
tion (unpublished data). We next examined the role of these
cytokines in DC maturation. The addition of anti–TNF- 
mAb at 20  g/ml partially inhibited phenotypic maturation
of immature DCs cultured with JR.2 (70% decrease in
CD83-positive cells compared with no antibody blocking)
while addition of anti–IFN-  at 20  g/ml did not inhibit
DC maturation as assessed by cell surface expression of
CD83 and CD86 using flow cytometry (Fig. 4 B). These re-
sults are consistent with production of a soluble factor such
as TNF-  being partially responsible for the CD1-mediated
Figure 4. Th1 cytokine production during JR.2:DC coculture is
CD1c dependent. (A) JR.2  /  T cells were incubated with immature
DCs for 24 h in the presence of blocking mAbs against CD1a, CD1c, or
an isotype-matched control antibody. The culture supernatants were
collected and assayed for TNF- , IFN- , IL-4, and IL-13. Note that
production of both TNF-  and IFN-  was inhibited by mAb against
CD1c but not CD1a. IL-4 and IL-13 were not detected (data not
shown). The sensitivity of the assay was 30 pg/ml. (B) Maturation of DCs
by JR.2 is partially mediated by TNF- . Immature DCs were cultured
for 48 h in medium or with  /  clone JR.2 (T cell:DC ratio   1:10) in
the presence of blocking mAbs against TNF-  or IFN- . DC up-regula-
tion of CD83 and CD86 was inhibited by the presence of mAbs against
TNF-  but not IFN- . The combination of mAbs against both TNF- 
and IFN-  was similar to the effect seen with TNF-  mAbs alone. These
results are representative of four independent experiments using different
DC donors.1580 CD1-mediated  /  T Cell Maturation of Dendritic Cells
maturation of DC by  /  T cells. We next employed a trans-
well system to determine if cell–cell contact was required
for maturation to occur. Immature DCs were cultured in di-
rect contact with the JR.2  /  clone or were separated by a
0.2   transwell membrane. DCs separated from JR.2 T cells
by the transwell failed to up-regulate CD83. To assess the
specific role of soluble factors, DCs and JR.2 were cocul-
tured together (T cell:DC ratio   1:10) and additional DCs
separated in the transwell were assayed for CD83 up-regula-
tion. The percentage of CD83  cells among the DCs ex-
posed to soluble factors in this transwell increased twofold
(20 to 40% positive), whereas DCs cultured in direct contact
with  /  clone JR.2 in the absence of a transwell demon-
strated a fourfold increase (20 to 80% positive; data not de-
picted). These results are consistent with production of a sol-
uble factor such as TNF  being only partially responsible for
the CD1-mediated maturation of DCs by  /  T cells. Other
investigators have emphasized the role of cell surface TNF
family members such as CD40 ligand (CD154; reference 6),
RANK ligand (7), and Fas ligand (8) expressed by T cells in
the maturation of DCs. As rapid, tightly regulated expression
of these cell surface T cell molecules may provide critical sig-
nals for DC maturation, we examined the expression of
CD40 ligand by  /  clone JR.2 during culture with imma-
ture DCs. CD40 ligand cell surface levels on JR.2 T cells in-
creased approximately fourfold (from MFI   21.3 to 84.23)
when cultured with CD1c expressing immature DCs over
24 h when compared with JR.2 T cells cultured in tissue
culture medium alone, implying a potential role for CD40
ligand in the maturation process (Fig. 5 A). Although CD40
ligand expression on the surface of the JR.2 T cells increased
during coculture with immature DCs, mAb blocking studies
using antibodies against CD40L led to only 20% inhibition
of CD83 up-regulation. In addition, mAb blocking of FasL,
as well as the RANKL antagonist OPG, also failed to signifi-
cantly inhibit maturation of DC as assessed by CD83 cell
surface expression (Fig. 5 B). Taken together, our results
emphasize the importance of soluble TNF-  production for
the maturation of DCs by the CD1-reactive  /  clone JR.2.
In addition, cell–cell contact between the DCs and CD1-
restricted  /  T cell clone appears to be required for optimal
maturation to occur, although we could not inhibit matura-
tion with blockage of FasL or RANKL and we observed
only partial inhibition via CD40L.
Both LPS and CD1-restricted  /  T Cells Are Required for
the Production of Heterodimeric IL-12 by Maturing DCs.
Maturation of DCs by microbial products such as LPS has
been proposed to lead to an “exhausted” DCs unable to
produce bioactive IL-12p70 upon subsequent ligation of
CD40 by antigen-specific naive CD4  T cells. Increasing
evidence suggests that signals derived from host T cells, in-
cluding soluble factors such as IFN-  as well as cell surface
molecules such as CD40L, may provide crucial second sig-
nals to the maturing DCs that are required for the produc-
tion of IL-12p70 (4). Therefore, we cultured immature
DCs in the presence of low levels of LPS alone (10 ng/ml)
or together with the CD1c-restricted  /  clone JR.2 and
assayed supernatants by ELISA for production of IL-12p70.
DCs cultured for 12 h in the presence of LPS or JR.2 alone
failed to produce IL-12 ( 30 pg/ml), whereas DCs cul-
tured in the presence of both LPS and JR.2 (T:DC ratio  
1:10) produced significant amounts of IL-12 (18.4   7.8
ng/ml). This effect could be partially inhibited by the addi-
tion of anti–IFN-  mAb ( 63% inhibition) suggesting a
role for this cytokine in the ability of these DCs to make
bioactive IL-12. The addition of mAb against CD1c also
efficiently blocked the production of IL-12 ( 87% inhibi-
tion) further supporting that recognition of CD1c ex-
pressed by the immature DCs by JR.2  /  T cells was crit-
ical for the production of IL-12 (Fig. 6).
DCs Matured by  /  T Cells Can Present Antigen to Naive
Human T Cells. One hallmark of mature DCs is their
Figure 5. Role of  /  T cell surface molecules and soluble mediators
in DC maturation. (A) CD40 ligand cell surface expression by JR.2.  / 
T cells. CD40 ligand expression on the surface of  /  T cell clone JR.2
increased approximately fourfold during a 24 h coculture with immature
DCs as assessed by mAb staining and flow cytometry. Triangles, culture
with DC; squares, medium control. (B) Inhibition of DC maturation by
blocking of  /  T cell surface molecules and the cytokines TNF-  and
IFN- . Immature DCs were cocultured with LPS (10 ng/ml) or JR.2 for
48 h. In the JR.2:DC cocultures the presence of mAb against TNF-  in-
hibited up-regulation of DCs expressing CD83 by  50%, while culture
in the presence of mAbs against IFN- , CD40L, FasL, or the RANKL
antagonist OPG had no effect. These results are representative of four in-
dependent experiments using different DC donors.1581 Leslie et al.
ability to present antigen to naive T cells encountered in
specialized locations such as the draining lymph node. This
interaction is critical for the development of an adaptive
immune response and the generation of immunologic
memory. We employed a system to determine if DCs, ma-
tured in the presence of the  /  T cell clone JR.2, were
able to efficiently present antigens to CD4  T cells. As ma-
ture DCs display an increased ability to stimulate allogeneic
CD4  T cells in a mixed lymphocyte reaction (MLR), we
first assessed the capacity of DCs matured in the presence of
 /  T cell clone JR.2 (T cell:DC ratio   1:3) or TNF- 
(50 ng/ml) to stimulate allogeneic CD4  T cells. CD4  T
cells were cultured for 7 d with irradiated allogeneic imma-
ture monocyte-derived DCs that had been previously cul-
tured for 72 h in the presence of TNF- , JR.2, or medium
alone. During the final 12 h of culture, cells were pulsed
with [3H]thymidine and assayed for proliferation. DCs ma-
tured in the presence of JR.2 or TNF-  led to increased
proliferation by allogeneic CD4  T cells when compared
with immature DCs that had been cultured in medium
alone (Fig. 7 A). We next employed a system to determine
if DCs, matured in the presence of the  /  T cell clone
JR.2, were able to efficiently present KLH, an antigen en-
countered for the first time, to naive T cells. Human
CD4 CD45RA  naive T cells were isolated using a nega-
tive selection mAb column. Autologous immature mono-
cyte-derived DCs were cultured for 72 h in the presence of
TNF-  (50 ng/ml),  /  clone JR.2 (T cell:DC ratio  
1:10), or medium alone with or without 25  g/ml KLH.
DCs cultured in either TNF-  (54% CD83 positive, CD86
MFI   608) or the presence of JR.2 (42% CD83 positive,
CD86 MFI   664) expressed increased levels of CD83 and
CD86 consistent with a mature DC phenotype. In con-
trast, the presence of KLH had no effect upon phenotypic
maturation (2.5% CD83 positive, CD86 MFI   16; data
not depicted). On day 3 of culture, these DCs were
washed, irradiated (5,000 rads), and then cultured with au-
tologous naive T cells at a DC:T cell ratio of 1 to 10 for
7 d. During the final 12 h of culture, cells were pulsed with
[3H]thymidine and assayed for proliferation. Only DCs
pulsed with KLH and matured in the presence of TNF- 
(SI   3.6) or the CD1c-restricted  /  T cell clone JR.2
Figure 6. IL-12p70 production by DCs requires both CD1-restricted
 /  T cells and LPS. Immature DCs were incubated for 24 h with the
JR.2  /  T cell clone, LPS (10 ng/ml), or both JR.2 and LPS in the pres-
ence of blocking mAbs against IFN- , CD1c, or CD1a. The culture su-
pernatants were collected and assayed for IL-12p70. Note that production
of IL-12p70 occurred only in the presence of both JR.2 and LPS and was
inhibited by mAb against IFN-  and CD1c but not CD1a. The sensitivity
of the assay was 0.3 ng/ml. These results are representative of three inde-
pendent experiments using different DC donors.
Figure 7.  /  clone JR.2 promotes DC antigen presentation to CD4 
T cells. (A) Allogeneic MLR. Immature monocyte-derived DCs were
cultured for 72 h in the presence of TNF- ,  /  clone JR.2, or medium
alone. Irradiated DC were then cultured at DC:T cell ratios from 1:1,000
to 1:10 with allogeneic CD4  T cells for 7 d and proliferation was mea-
sured. DCs that had been matured in the presence of TNF-  or  / 
clone JR.2 resulted in increased proliferation of allogeneic CD4  T cells
when compared with immature DCs. Squares, medium alone; inverted
triangles, TNF- ; diamonds, JR.2. (B) KLH antigen presentation. Imma-
ture monocyte-derived DCs were cultured for 72 h in the presence of
TNF- ,  /  clone JR.2, or medium alone in the presence or absence of
25   g/ml Keyhole Limpet Hemacyanin (KLH). Irradiated DCs were
then cultured with 5   104 autologous CD4 CD45RA  naive T cells/
well at a DC:T cell ratio of 1:10 for 5 d and proliferation was measured.
Only DCs pulsed with KLH and matured in the presence of TNF  or  / 
clone JR.2 resulted in proliferation by naive responder T cells. Results are
expressed as relative stimulation index. Results are representative of two
independent experiments using different DC donors.1582 CD1-mediated  /  T Cell Maturation of Dendritic Cells
(SI   5) led to specific proliferation by the naive T cells re-
active against KLH (Fig. 7 B).
Discussion
We have described and functionally characterized the
ability of  /  T cells to mediate CD1-dependent matura-
tion of monocyte-derived DCs. These CD1-reactive T cells
express V 1 TCR specificities characteristic of the predom-
inant  /  subset present in tissues and represent an attractive
candidate for a host T cell population that could provide
critical signals for the development of a fully functional DC
population at an early point during microbial infection.
Studies in both mice and humans have implicated  /  T
cells in host defense. For example,  /  T cells modulate
the severity of disease or mediate a component of protec-
tive immunity in murine models of listeriosis, tuberculosis,
malaria, and HSV-1 encephalitis. In humans,  /  T cells
expressing V 2V 2 TCRs are dramatically expanded dur-
ing infection with Listeria monocytogenes, Mycobacterium tu-
berculosis, Brucella melitensis, and Ehrlichia chaffeensis (23). Ad-
ditionally,  /  T cells expressing V 1 TCR specificities are
expanded during HIV (24, 25) and malarial (26) infections.
Recent evidence has demonstrated that the antigens recog-
nized by the V 2V 2  /  T cell subset, the predominant
 /  population in the blood, are small nonpeptide mole-
cules containing alkylphosphate (27, 28), alkylamine (29),
and bisphosphonate moieties (30). Further, V 2V 2 T cells
display a memory-type response to these antigens in BCG-
vaccinated macaque monkeys and provide immunity to
subsequent challenge with Mycobacterium tuberculosis (31). In
contrast, human  /  T cells bearing V 1-encoded TCRs
account for the vast majority of  /  T cells in tissues such
as the spleen and intestine (32) yet the antigens that they
recognize remain enigmatic. Recent studies have demon-
strated that a subset of V 1   /  T cells can recognize
stress inducible MHC class I–like MIC molecules expressed
by epithelial cells via specific TCR interactions (33). We
have previously demonstrated that this major tissue popula-
tion of  /  T cells expressing V 1-encoded TCRs recog-
nizes CD1c, one member of a family of nonpolymorphic
CD1 molecules expressed on the surface of DCs and B
cells, that present lipid and glycolipid foreign antigens to T
cells (13). Importantly, this recognition of CD1c occurred
in the absence of exogenous foreign antigens, implying re-
activity against as yet to be identified self- lipids.
Here, we demonstrated the capacity of V 1 T cells to
recognize CD1 on immature DCs and induce their matu-
ration. Hence, based upon their location in the tissues and
their recognition of CD1c, these T cells may be uniquely
poised to interact with immature DCs during the earliest
time points during microbial infection. Although the  / 
T cell population that we have described here expresses
V 1 TCR specificities characteristic of the  /  subpopula-
tion predominant in peripheral tissues, recent evidence
suggests that these cells are also present in the lymph nodes
(M. Brandes and B. Moser, personal communication).
Thus, they may encounter recently activated DCs either in
tissues or in draining lymph nodes.
Signals derived from host T cells play a critical role in the
generation of mature DCs capable of effectively polarizing
naive antigen-specific T cells to produce Th1 cytokines.
Although microbial products such as LPS can effectively
promote maturation and the initial production of IL-12 by
the DCs, in the absence of additional host-derived signals
such as IFN- , these DCs rapidly lose the capacity to pro-
duce IL-12 upon subsequent CD40 ligation by naive T
cells (4). Several host cell types have been proposed as can-
didates to provide such signals to the maturing DCs.
CD45RA  CD8 T cells can rapidly produce IFN-  and
TNF-  and augment the ability of the maturing DCs to
polarize naive CD4  T cells toward a Th1 response (21).
However, in the naive host the pool of antigen-specific
CD8 T cells available to provide such signals at the site of a
microbial infection would likely be small, limiting the
amount of these cytokines available to DCs during their
initial exposure to a microbe. Similarly, NK cells can also
provide IFN-  and TNF-  to maturing DCs but this in-
teraction would also seem to be limited by the availability
of these cells at the site of infection and require prior acti-
vation of this pool of NK cells (22). In addition, it has re-
cently been reported that phosphoantigen-reactive  /  T
cells, which are not CD1-restricted, can promote DC mat-
uration under specific activating conditions (34). The
CD1c self-reactive  /  T cells characterized here, express
V 1 TCR specificities characteristic of the subpopulation
of  /  T cells that predominates in tissues. Additionally,
these cells are able to promote DC maturation via CD1
recognition without the requirement for specific recogni-
tion of microbial antigens. Therefore, we suggest based
upon their location at the site infection and their ability to
mediate DC maturation via recognition of CD1 that this
important population of T cells can provide the host with
the ability to rapidly generate a pool of mature DCs able to
polarize naive T cells during subsequent encounter in the
secondary lymphoid tissues. DCs matured in the presence
of CD1-restricted  /  T cells expressed increased levels of
costimulatory molecules, decreased antigen uptake, and re-
distribution of MHC class II molecules consistent with
functional maturation. This CD1c-dependent maturation
was partially mediated by TNF-  and required cell–cell
contact. In addition, these mature DCs were able to effi-
ciently present a protein antigen not previously encoun-
tered, such as KLH, to naive CD4  T cells. Finally, our
data demonstrate that DCs require both a microbial signal,
LPS, as well as IFN-  produced by CD1-reactive  /  T
cells for production of heterodimeric IL-12. Thus, CD1-
reactive  /  T cells may provide critical signals for Th1 po-
larization of naive antigen-specific CD4 T cells.
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